Inhibikase Therapeutics

NasdaqCM:IKT Stock Report

Mkt Cap: US$23.0m

Inhibikase Therapeutics Company Information

Inhibikase Therapeutics, Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: Inhibikase Therapeutics, Inc.
  • Ticker: IKT
  • Exchange: NasdaqCM
  • Founded: 2008
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Implied Market Cap: US$22.957m
  • Shares outstanding: 25.23m
  • Website: https://www.inhibikase.com

Number of Employees


Location

  • Inhibikase Therapeutics, Inc.
  • 3350 Riverwood Parkway SE
  • Suite 1900
  • Atlanta
  • Georgia
  • 30339
  • United States


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
IKTNasdaqCM (Nasdaq Capital Market)YesCommon StockUSUSDDec 2020
IQTDB (Deutsche Boerse AG)YesCommon StockDEEURDec 2020

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/09/30 00:00
End of Day Share Price2022/09/30 00:00
Earnings2022/06/30
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.